REVIEW
|
doi:10.20944/preprints202307.1242.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immune checkpoint inhibitors (ICIs); Non–small cell lung cancer (NSCLC); PD-1 , PD-L1; CTLA-4
Online: 19 July 2023 (02:48:47 CEST)